StockData
ANI Pharmaceuticals Inc logo

ANI Pharmaceuticals Inc (ANIP) bonds

ANIPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 14/3048% below fair value
$69.99−0.90 (-1.27%)

Close on Nov 17, 2026Market cap $1.61BP/E 14.9Yield –

Debt

Borrowings on the balance sheet, Jun 30, 2026

Total debt
$301.48M
$21.33M due within a year
Net debt
-$58.73M
After $360.21M of cash
Implied interest rate
10.38%
FY2025 interest ÷ average debt
Interest coverage
3.4×
FY2025 operating income ÷ interest

Total debt by fiscal year

Long-term plus current debt, USD

Notes and loans outstanding

As tagged in ANI Pharmaceuticals's 10-Q for the period ended Jun 30, 2026

IssueCouponMaturesAmount issued
Convertible Senior Notes due 2029
Convertible
2.25%2029$316.30M

Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.

Credit facilities

Revolving credit lines and other committed borrowing capacity

FacilitySizeDrawn
2024 Credit Agreement$325.00M$280.16M
Credit Facility - 2021$300.00M$292.50M
Credit Facility - 2021$40.00M–

See a number that looks wrong?